DNA, RNA stabilization reagents
April 2014—In a licensing agreement between Biomatrica and ATCC, Biomatrica will supply DNAstable and RNAstable reagents for the stabilization of DNA and RNA standards.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
April 2014—In a licensing agreement between Biomatrica and ATCC, Biomatrica will supply DNAstable and RNAstable reagents for the stabilization of DNA and RNA standards.
April 2014—Finnish health care company Biohit Oyj and Randox Laboratories signed a licensing agreement giving Randox the worldwide licensing rights for GastroPanel.
April 2014—IMDx’s artus C. difficile QS-RGQ kit received CE marking for use with QIAsymphony SP/AS and Rotor-Gene Q instruments. Concurrently, in December 2013, a Premarket Notification 510(k) for the test was submitted to the FDA for review.
April 2014—Trinity Biotech’s Meritas Troponin I (TnI) point-of-care test obtained CE marking. The test enables accurate triage and intervention for emergency department patients with possible myocardial infarction; results are available in 15 minutes.
April 2014—Terumo BCT received FDA 510(k) clearance for red blood cell exchange on the Spectra Optia Apheresis System.
April 2014—Vector Laboratories’ Avidin-HRP and Streptavidin-HRP are optimized to yield high signal-to-noise ratios in solid phase assays, such as ELISAs and blotting applications.
April 2014—Audit MicroControls launched a new Web site, adding online ordering, access to Auditor QC, peer review data retrieval, and search functions by instrument, analyte, or indication. It also offers information about quality control products, calibration verification/linearity products, Audit Ship, and Audit Faxback.
April 2014—Audit MicroControls added to its line of products the Control LQ Glycohemoglobin A1c—a liquid bi-level reference control consisting of human blood–based solutions.
April 2014—Dako entered into a master framework agreement with Merck to develop companion diagnostic tests for oncology drugs currently in Merck’s development pipeline.
March 2014—The sixth edition of The Educational Guidebook: IHC Staining Methods, published by Dako, is now available. The guidebook is used as a teaching and learning tool worldwide and serves as a reference for ensuring correct staining processes within the lab. Several experts within the field of IHC wrote this new edition and Clive R. Taylor, MD, is the editor.